These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25664838)

  • 1. Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity.
    Wolfs MG; Gruben N; Rensen SS; Verdam FJ; Greve JW; Driessen A; Wijmenga C; Buurman WA; Franke L; Scheja L; Koonen DP; Shiri-Sverdlov R; van Haeften TW; Hofker MH; Fu J
    Nutr Diabetes; 2015 Feb; 5(2):e146. PubMed ID: 25664838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
    Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity.
    Bekaert M; Ouwens DM; Hörbelt T; Van de Velde F; Fahlbusch P; Herzfeld de Wiza D; Van Nieuwenhove Y; Calders P; Praet M; Hoorens A; Geerts A; Verhelst X; Kaufman JM; Lapauw B
    Obesity (Silver Spring); 2016 Dec; 24(12):2544-2552. PubMed ID: 27768254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
    Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA
    Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease.
    Estep M; Armistead D; Hossain N; Elarainy H; Goodman Z; Baranova A; Chandhoke V; Younossi ZM
    Aliment Pharmacol Ther; 2010 Aug; 32(3):487-97. PubMed ID: 20497147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease.
    Jin R; Krasinskas A; Le NA; Konomi JV; Holzberg J; Romero R; Vos MB
    Pediatr Obes; 2018 Jan; 13(1):23-29. PubMed ID: 27764892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes.
    Samaras K; Botelho NK; Chisholm DJ; Lord RV
    Obesity (Silver Spring); 2010 May; 18(5):884-9. PubMed ID: 20019678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance.
    Kwak MS; Kim D; Chung GE; Kim W; Kim YJ; Yoon JH
    Liver Int; 2015 Mar; 35(3):944-52. PubMed ID: 24684289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease.
    Fitzpatrick E; Dew TK; Quaglia A; Sherwood RA; Mitry RR; Dhawan A
    Pediatr Obes; 2012 Dec; 7(6):471-9. PubMed ID: 22962039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose tissue quantity and composition contribute to adipokine concentrations in the subclavian vein and the inferior mesenteric vein.
    Faber DR; Moll FL; Vink A; van der Waal C; Kalkhoven E; Schipper HS; Hajer GR; Monajemi H; Visseren FL
    Int J Obes (Lond); 2012 Aug; 36(8):1078-85. PubMed ID: 22064157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease.
    Boutari C; Perakakis N; Mantzoros CS
    Endocrinol Metab (Seoul); 2018 Mar; 33(1):33-43. PubMed ID: 29589386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
    Yoneda M; Iwasaki T; Fujita K; Kirikoshi H; Inamori M; Nozaki Y; Maeyama S; Wada K; Saito S; Terauchi Y; Nakajima A
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S15-21. PubMed ID: 17331160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
    Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
    Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
    Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease.
    Candia R; Riquelme A; Baudrand R; Carvajal CA; Morales M; Solís N; Pizarro M; Escalona A; Carrasco G; Boza C; Pérez G; Padilla O; Cerda J; Fardella CE; Arrese M
    Liver Int; 2012 Mar; 32(3):392-9. PubMed ID: 22136330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.
    Wajchenberg BL; Giannella-Neto D; da Silva ME; Santos RF
    Horm Metab Res; 2002; 34(11-12):616-21. PubMed ID: 12660870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease.
    Abenavoli L; Luigiano C; Guzzi PH; Milic N; Morace C; Stelitano L; Consolo P; Miraglia S; Fagoonee S; Virgilio C; Luzza F; De Lorenzo A; Pellicano R
    Panminerva Med; 2014 Jun; 56(2):189-93. PubMed ID: 24994581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
    Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
    Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.
    Aron-Wisnewsky J; Minville C; Tordjman J; Lévy P; Bouillot JL; Basdevant A; Bedossa P; Clément K; Pépin JL
    J Hepatol; 2012 Jan; 56(1):225-33. PubMed ID: 21703181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.